Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,756 across all filing types
Latest filing 2025-05-20 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2025-05-20 English
Dividend updated
Regulatory Filings
2025-05-20 English
Date of payment of Final Dividend 2024-25
Regulatory Filings
2025-05-20 English
Dividend Update
Regulatory Filings
2025-05-20 English
Appointment of Secretarial Auditor
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) disclosing the appointment of a Secretarial Auditor. It references compliance with SEBI regulations and provides details about the appointment, including the term and the profile of the appointed firm. There are no financial statements, earnings data, or detailed management discussion. The document is an announcement of a board decision regarding management/board-related changes, specifically the appointment of an auditor. This fits the category of Board/Management Information (MANG). The document length is 4691 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2025-05-20 English
Updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) disclosing the appointment of a Secretarial Auditor. It references compliance with SEBI regulations and provides details about the appointment, including the term and profile of the auditor firm. The document is dated May 20, 2025, and mentions the Board meeting approving the appointment. There are no financial statements, earnings data, or detailed management discussion. The content is an announcement of a board decision regarding management/audit appointments rather than a full report or financial disclosure. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management roles, including auditor appointments.
2025-05-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.